Drug Type Chemical drugs |
Synonyms |
Target |
Action modulators |
Mechanism mTORC1 modulators(Mammalian target of Rapamycin (mTORC1) modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
disorder of aging | Preclinical | United States | 07 May 2024 | |
Metabolic Diseases | Preclinical | United States | 07 May 2024 |